|

Short course of blinatumomab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Hospital Universitario Dr. Jose E. Gonzalez1

Indications

  • Measurable Residual Disease (MRD)1
  • Acute Lymphoblastic Leukemia1
  • Cancer1

Other1 trial

Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.